Alyeska Investment Group, L.P. Lucid Diagnostics Inc. Call Options Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LUCD
# of Institutions
47Shares Held
9.24MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$3.38 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$1.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$569,2400.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$566,2380.62% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT422KShares$523,2840.24% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $47.8M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...